A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy
Nature Nanotechnology · 2024-10 · 19 (10) · 1558-1568
DOI: 10.1038/s41565-024-01736-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Nanotechnology, online erschienen am 23.07.2024. Verfasst von Yanqin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, Chi…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Bone Marrow. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China (National Science Foundation of China), Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation).
Abstract (Originalsprache)
Haematologic malignancies commonly arise from the bone marrow lesion, yet there are currently no effective targeted therapies against tumour cells in this location. Here we constructed a bone-marrow-targeting nanosystem, CSF@E-Hn, which is based on haematopoietic-stem-cell-derived nanovesicles adorned with gripper ligands (aPD-L1 and aNKG2D) and encapsulated with colony-stimulating factor (CSF) for the treatment of haematologic malignancies. CSF@E-Hn targets the bone marrow and, thanks to the gripper ligands, pulls together tumour cells and natural killer cells, activating the latter for specific tumour cell targeting and elimination. The therapeutic efficacy was validated in mice bearing acute myeloid leukaemia and multiple myeloma. The comprehensive assessment of the post-treatment bone marrow microenvironment revealed that the integration of CSF into a bone-marrow-targeted nanosystem promoted haematopoietic stem cell differentiation, boosted memory T cell generation and maintained bone homoeostasis, with long-term prevention of relapse. Our nanosystem represents a promising strategy for the treatment of haematologic malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China.
- State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China. gusubmit@163.com.
- State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China. lsw@cpu.edu.cn.
Förderung
- National Natural Science Foundation of China (National Science Foundation of China)
- Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation)
Zitieren
APA
Zhang, Y., Deng, Y., Zhai, Y., Li, Y., Li, Y., Li, J., Gu, Y., & Li, S. (2024). A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy. Nature Nanotechnology, 19(10), 1558-1568. https://doi.org/10.1038/s41565-024-01736-9
Vancouver
Zhang Y, Deng Y, Zhai Y, Li Y, Li Y, Li J, et al. A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy. Nature Nanotechnology. 2024;19(10):1558-1568. doi:10.1038/s41565-024-01736-9
BibTeX
@article{Zhang2024,
author = {Zhang, Yanqin and Deng, Yanfang and Zhai, Yuewen and Li, Yu and Li, Yuting and Li, Juequan and Gu, Yueqing and Li, Siwen},
title = {A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy},
journal = {Nature Nanotechnology},
year = {2024},
volume = {19},
number = {10},
pages = {1558--1568},
doi = {10.1038/s41565-024-01736-9}
}
EUVIMED